Precision Virologics, Inc. — Form D
Precision Virologics, Inc. of ST. LOUIS, MO, a company, filed a Form D exempt-offering notice with the SEC on 2017-04-18. The offering totals $1.0M, of which $500K was reported sold. Industry: Other Health Care.
Offering
- Filed: 2017-04-18
- Form: D
- Accession: 0001704095-17-000001
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $1.0M
- Amount sold: $500K
- Remaining: $500K
- Minimum investment: $50K
- Investors: 1
- Date of first sale: 2017-04-03
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-285018
Issuer
- Name: Precision Virologics, Inc.
- CIK: 0001704095
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: 4320 FOREST PARK AVENUE, SUITE 304, ST. LOUIS, MO, 63108
- Phone: (314) 730-0050
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| David T Curiel | Director | St. Louis, MO |
| Yasunari E Kashihara | Director | Fort Lee, NJ |
| Daniel E Katzman | Director | St. Louis, MO |
| David T Curiel | Executive Officer | St. Louis, MO |
| Daniel E Katzman | Executive Officer | St. Louis, MO |
More